Raza Bokhari - Media Placements



Click on link to view PDF or video

	Making a Living - Transforming Healthcare From the Bucks County Courier by JOHN ANASTASI - STAFF WRITER
	Philadelphia Business Journal 2007 Ernst & Young Entrepreneur of the Year - Finalist
	Philadelphia Business Journal Alumnus gives $lM to Temple's Fox School for project
	Temple Times Young entrepreneur makes $1 million gift to Fox School of Business
	The Trend Villanova resident gives back to Temple
	Philadelphia Business Journal Lab firm gets $50M infusion
	Philadelphia Business Journal Parkway Clinical Labratories Wins Best Places to Work


	Raza Bokhari Interview with Executive Leaders Radio
	CSPAN Interview
	World Affairs Council - Pakistan: A Nation in Crisis, A World at Risk
	WPHT AM - Michael Smerconish talk show: Islamabad bombing
	Dr. Raza Bokhari talks about the impact of the Mumbai terrorist attack on the U.S. led global war on terrorism on the Michael Smerconish talk show.
	Raza Bokhari Interviewed by Executive Leaders Radio - August 21, 2009. Raza describes his entrepreneurial journey with Executive Leaders radio talk show host Herb Cohen.
	Raza is interviewed on the Bob Rover Talks to the Stars radio program. Raza discuses the current situation in Pakistan, President Musharraf and his US-Pakistan Focused Public-Private Partnership Investment Fund, Building Beyond BRIC Investment Fund, LP, on Bob Rovner Talks to the Stars.


	Temple Lecture
	Dr. Raza Bokhari appears on Comcast “Newsmakers”
	Dr. Raza Bokhari appears on NBC-10
	Dr. Raza Bokhari interviewed on Jaiza

FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND

Sept 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari speaks about filing with the FDA an IND Application to initiate phase 2 clinical trial to treat hospitalized COVID-19 patients.

Click here to watch the full video

FSD Pharma says $10M in new capital is 'gratifying' as the firm makes progress in coronavirus trial

August 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari, on Proactive Investors spoke about completing US$10 million registered offering and provides progress update on submitting IND Application to the FDA to use FSD201 to treat COVID-19 patients.

Click here to watch the full video

FSD Pharma – FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients

July 2, 2020

Dr Raza Bokhari, FSD Pharma CEO, talks about developing its ultra micro PEA Compound to treat COVID-19....

Click here to watch the video.

View Archive